Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014855 |
| CAS No | NA |
| Mol.F. | C20H20F2N4O4 |
| Mol.Wt. | 418.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014856 |
| CAS No | NA |
| Mol.F. | C22H26N4O6 |
| Mol.Wt. | 442.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014857 |
| CAS No | NA |
| Mol.F. | C22H25FN4O5 |
| Mol.Wt. | 444.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014858 |
| CAS No | NA |
| Mol.F. | C21H23FN4O5 |
| Mol.Wt. | 430.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014859 |
| CAS No | NA |
| Mol.F. | C21H23FN4O5 |
| Mol.Wt. | 430.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014860 |
| CAS No | NA |
| Mol.F. | C20H23FN4O3 |
| Mol.Wt. | 386.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014861 |
| CAS No | NA |
| Mol.F. | C9H13N3O |
| Mol.Wt. | 179.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014862 |
| CAS No | NA |
| Mol.F. | C14H16N4O |
| Mol.Wt. | 256.3 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014863 |
| CAS No | 146897-60-1 |
| Mol.F. | C8H8N2O3 |
| Mol.Wt. | 180.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014864 |
| CAS No | 938-81-8 |
| Mol.F. | C8H8N2O2 |
| Mol.Wt. | 164.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014865 |
| CAS No | NA |
| Mol.F. | C12H10N2O3 |
| Mol.Wt. | 230.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014866 |
| CAS No | NA |
| Mol.F. | C4H10N6O |
| Mol.Wt. | 158.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N014867 |
| CAS No | NA |
| Mol.F. | C2H3N5O |
| Mol.Wt. | 113.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014868 |
| CAS No | NA |
| Mol.F. | C3H8N6O |
| Mol.Wt. | 144.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014869 |
| CAS No | NA |
| Mol.F. | C3H8N6O |
| Mol.Wt. | 144.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014870 |
| CAS No | NA |
| Mol.F. | C10H6N2O4 |
| Mol.Wt. | 218.2 |
| INV STATUS | CUSTOM SYNTHESIS |